STEPHANIE HOLDERMAN: Open Payments
NPI 1083215917 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,679 in 169 payments from 19 companies in 2025. Trend: 2023 $3,788 · 2024 $3,202 · 2025 $2,679
Food & beverage: $2,679
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 16 | $324 |
| Janssen Pharmaceuticals, Inc | 18 | $313 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $304 |
| ABBVIE INC. | 21 | $278 |
| Otsuka America Pharmaceutical, Inc. | 17 | $227 |
| Vanda Pharmaceuticals Inc. | 22 | $209 |
| E.R. Squibb & Sons, L.L.C. | 9 | $191 |
| Axsome Therapeutics, Inc. | 9 | $149 |
| Supernus Pharmaceuticals, Inc. | 11 | $147 |
| Neurocrine BioSciences, Inc. | 6 | $105 |
Products named: ARISTADA, CAPLYTA, VRAYLAR, INVEGA SUSTENNA, COBENFY, HETLIOZ, Auvelity, Qelbree.
Industry payments across NC — which companies pay providers there.
